Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis

NCT01510535 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

287

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of the Knee

Interventions

DRUG: Placebo
DRUG: Hyruan Plus
DRUG: LBSA0103

Sponsor

LG Life Sciences